Abington Neurological Associates

08/31/2025

ANA will be closed tomorrow, Monday, Sept 1st for the Labor Day holiday. The practice will re-open Tuesday, Sept. 2nd.
🇺🇸

08/29/2025

Did you know...
👉More than 6 million Americans are living with Alzheimer's
👉1 in 3 seniors dies with Alzheimer's or another dementia. It kills more than breast cancer and prostate cancer combined.
👉The lifetime risk for Alzheimer’s at age 45 is 1 in 5 for women and 1 in 10 for men.
👉Between 2020 and 2030, 1.2 million additional direct care workers will be needed to care for the growing population of people living with dementia — the largest worker gap in the U.S.
👉In 2023, Alzheimer’s and other dementias will cost the nation $345 billion. By 2050, these costs could rise to nearly $1 trillion.

There are ways to help! Stay informed, advocate and invest in Research!

08/27/2025

https://www.brainandlife.org/articles/poor-sleep-middle-age-speed-brain-aging

Sleep problems in midlife may accelerate brain aging, with links to dementia risk. Early diagnosis and treatment are key to preserving brain health.

08/25/2025

08/20/2025

Please join us in welcoming Dr. Minsoo Kim to ANA!

Dr. Minsoo Kim is a board-certified neurologist specializing in neuromuscular medicine. After earning his medical degree from the Medical School for International Health (a collaboration between Ben-Gurion University in Israel and Columbia University), he completed a Neurology Residency at Saint Louis University, followed by a Neuromuscular Medicine Fellowship at Washington University in St. Louis.

His professional journey has taken him from Washington to Ohio and then to Reston, Virginia, where he recently practiced at the Virginia Spine Institute. With extensive training and experience across diverse clinical settings, Dr. Kim is skilled in advanced diagnostic and therapeutic techniques, including nerve conduction studies (NCS), electromyography (EMG), Botox injections, and management of complex neuromuscular disorders.

Dr. Kim’s research and clinical interests are showcased in multiple peer-reviewed publications and posters, particularly relating to small fiber neuropathy in pediatric populations. Dr. Kim served as a sub-investigator in five clinical trials that involved ALS, CMT, FSHD, inflammatory myositis, and dermatomyositis. He has coauthored articles in the Journal of Clinical Neuromuscular Disease and presented his work at esteemed conferences such as the American Academy of Neurology and the American Association of Neuromuscular & Electrodiagnostic Medicine.

08/19/2025

https://www.brainandlife.org/articles/whitney-cummings-migraines-changed-life-made-her-stronger

Learning to better care for herself helped comedian Whitney Cummings find relief after years of debilitating migraine attacks.

05/14/2025

Panelists discuss how managing ARIA risk in patients receiving lecanemab or donanemab requires structured MRI monitoring, multidisciplinary coordination, and patient education to ensure safe treatment while maximizing the benefits of amyloid-lowering therapies in early Alzheimer disease.

05/09/2025

A huge shout-out to the rockstar nurses at ANA! We appreciate everything you do each and everyday for our patients! 🥰

05/09/2025

Dr. David Weisman, Clinical Research Director at ANA speaks on NeurologyLive offering insight on treatment options for Early onset Alzheimer Disease.

Panelists discuss how clinical experience with lecanemab in early Alzheimer disease shows meaningful slowing of cognitive and functional decline, with observed benefits to quality of life, caregiver confidence, and daily independence—highlighting the importance of early diagnosis, biomarker confir...

04/22/2025

Happy Earth Day! 🌎🌳🌻🌱🌊🌞